Diagnosis and treatment of pregnancy complicated with adrenal insufficiency

doi:10.3877/cma.j.issn.2095-3259.2024.01.002

Abstract

Abstract:

Pregnancy complicated with adrenal insufficiency is rare in clinical practice. Many obstetricians have limited experience in dealing with such diseases, and this poses a great challenge to early diagnosis and standardized treatment of pregnant women with such kind of diseases. This article focuses on the diagnosis and treatment, pregnancy outcomes, perinatal management, breastfeeding, and patient education of pregnancy complicated with adrenal insufficiency.

Key words: Addison disease, Diagnosis, Therapeutics, Pregnancy

Tong Zou, Qiang Yao. Diagnosis and treatment of pregnancy complicated with adrenal insufficiency[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(01): 6-12.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2024.01.002

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2024/V13/I01/6

References 47

[1]	Husebye ES, Pearce SH, Krone NP, et al. Adrenal insufficiency[J]. Lancet (London, England)，2021，397(10274)：613-629.
[2]	中华医学会内分泌学分会肥胖学组. 肾上腺皮质功能减退症患者围手术期糖皮质激素管理专家共识[J]. 中华内分泌代谢杂志，2022，38(1)：1-6.
[3]	Eaton WW, Rose NR, Kalaydjian A, et al. Epidemiology of autoimmune diseases in Denmark[J]. J Autoimmun，2007，29(1)：1-9.
[4]	LøVåS K, Husebye ES. High prevalence and increasing incidence of Addison′s disease in western Norway[J]. Clin Endocrinol，2002，56(6)：787-791.
[5]	Olafsson AS, Sigurjonsdottir HA. Increasing prevalence of Addison disease: results from a nationwide study[J]. Endocr Pract，2016，22(1)：30-35.
[6]	Laureti S, Vecchi L, Santeusanio F, et al. Is the prevalence of Addison′s disease underestimated？[J]. J Clin Endocrinol Metab，1999，84(5)：1-5.
[7]	Hong AR, Ryu OH, Kim SY, et al. Characteristics of Korean patients with primary adrenal insufficiency: a registry-based nationwide survey in Korea[J]. Endocrinol Metab (Seoul)，2017，32(4)：466-474.
[8]	Takayanagi R, Miura K, Nakagawa H, et al. Epidemiologic study of adrenal gland disorders in Japan[J]. Biomed Pharmacother，2000，54 Suppl 1：164s-168s.
[9]	Calina D, Docea AO, Golokhvast KS, et al. Management of endocrinopathies in pregnancy: a review of current evidence[J]. Int J Environ Res Public Health，2019，16(5)：1-25.
[10]	Schneiderman M, Czuzoj-Shulman N, Spence AR, et al. Maternal and neonatal outcomes of pregnancies in women with Addison′s disease: a population-based cohort study on 7.7 million births[J]. BJOG，2017，124(11)：1772-1779.
[11]	Langlois F, Lim DST, Fleseriu M. Update on adrenal insufficiency: diagnosis and management in pregnancy[J]. Curr Opin Endocrinol Diabetes Obes，2017，24(3)：184-192.
[12]	Woodcock T, Barker P, Daniel S, et al. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK[J]. Anaesthesia，2020，75(5)：654-663.
[13]	Carr BR, Parker CR Jr, Madden JD, et al. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy[J]. Am J Obstet Gynecol，1981，139(4)：416-422.
[14]	Anand G, Beuschlein F. Management of endocrine disease: fertility, pregnancy and lactation in women with adrenal insufficiency[J]. Eur J Endocrinol，2018，178(2)：R45-53.
[15]	Frise CJ, Williamson C. Endocrine disease in pregnancy[J]. Clin Med (Lond)，2013，13(2)：176-181.
[16]	Motosko CC, Bieber AK, Pomeranz MK, et al. Physiologic changes of pregnancy: a review of the literature[J]. Int J Womens Dermatol，2017，3(4)：219-224.
[17]	Richardson BS, Wakim E, Dasilva O, et al. Preterm histologic chorioamnionitis: impact on cord gas and pH values and neonatal outcome[J]. Am J Obstet Gynecol，2006，195(5)：1357-1365.
[18]	Manoharan M, Sinha P, Sibtain S. Adrenal disorders in pregnancy, labour and postpartum - an overview[J]. J Obstet Gynaecol，2020，40(6)：749-758.
[19]	Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility[J]. Stress，2018，21(5)：403-416.
[20]	Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab，2016，101(2)：364-389.
[21]	Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab，2016，101(11)：3888-3921.
[22]	Yanase T, Tajima T, Katabami T, et al. Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline [Opinion][J]. Endocr J，2016，63(9)：765-784.
[23]	Suri D, Moran J, Hibbard JU, et al. Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test[J]. J Clin Endocrinol Metab，2006，91(10)：3866-3872.
[24]	Bancos I, Hahner S, Tomlinson J, et al. Diagnosis and management of adrenal insufficiency[J]. Lancet Diabetes Endocrinol，2015，3(3)：216-226.
[25]	Shrivastava S, Chen B, Dworkin LD, et al. Relapse of Nephrotic Syndrome after adrenocorticotropic hormone-induced remission: implications of adrenocorticotropic hormone antibodies[J]. Am J Nephrol，2020，51(5)：390-394.
[26]	陈家伦. 临床内分泌学[M]. 上海：上海科学技术出版社，2011：549-554.
[27]	Schmidt IL, Lahner H, Mann K, et al. Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease[J]. J Clin Endocrinol Metab，2003，88(9)：4193-4198.
[28]	Lebbe M, Arlt W. What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy？[J]. Clin Endocrinol，2013，78(4)：497-502.
[29]	葛均波，徐永健. 内科学[M]. 9版．北京：人民卫生出版社，2018：713-715.
[30]	Arlt W, Callies F, Van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency[J]. N Engl J Med，1999，341(14)：1013-1020.
[31]	Wierman ME, Arlt W, Basson R, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab，2014，99(10)：3489-3510.
[32]	Esteban NV, Loughlin T, Yergey AL, et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry[J]. J Clin Endocrinol Metab，1991，72(1)：39-45.
[33]	Plat L, Leproult R, L′Hermite-Baleriaux M, et al. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning[J]. J Clin Endocrinol Metab，1999，84(9)：3082-3092.
[34]	Isidori AM, Venneri MA, Graziadio C, et al. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial[J]. Lancet Diabetes Endocrinol，2018，6(3)：173-185.
[35]	Johannsson G, Nilsson AG, Bergthorsdottir R, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation[J]. J Clin Endocrinol Metab，2012，97(2)：473-481.
[36]	Guarnotta V, Ciresi A, Pillitteri G, et al. Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month retrospective analysis[J]. Clin Endocrinol，2018，88(5)：665-672.
[37]	Nilsson AG, Bergthorsdottir R, Burman P, et al. Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study[J]. Eur J Endocrinol，2017，176(6)：715-725.
[38]	Frey KR, Kienitz T, Schulz J, et al. Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency[J]. Endocr Connect，2018，7(6)：811-818.
[39]	Quinkler M, Ekman B, Marelli C, et al. Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency[J]. Endocr Eonnect，2017，6(1)：1-8.
[40]	Quinkler M, Hahner S, Johannsson G, et al. Saving lives of patients with adrenal insufficiency: a pan-European initiative？[J]. Clin Endocrinol，2014，80(3)：319-321.
[41]	Hahner S, Loeffler M, Bleicken B, et al. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies[J]. Eur J Endocrinol，2010，162(3)：597-602.
[42]	Lekarev O, New MI. Adrenal disease in pregnancy[J]. Best Pract Res Clin Endocrinol Metab，2011，25(6)：959-973.
[43]	Ahmed M, Bashir M, Okunoye GO, et al. Adrenal disease and pregnancy: an overview[J]. Obstet Gynaecol，2021，23(4)：265-277.
[44]	Bothou C, Anand G, Li D, et al. Current management and outcome of pregnancies in women with adrenal insufficiency: experience from a multicenter survey[J]. J Clin Endocrinol Metab，2020，105(8)：e2853-2863.
[45]	Cheang KI, Sharma ST, Nestler JE. Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome？[J]. Gynecol Endocrinol，2006，22(11)：595-604.
[46]	Greenberger PA, Odeh YK, Frederiksen MC, et al. Pharmacokinetics of prednisolone transfer to breast milk[J]. Clin Pharmacol Ther，1993，53(3)：324-328.
[47]	Arlt W, Society for Endocrinology Clinical Committee. Society For Endocrinology Endocrine emergency guidance: emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients[J]. Endocr Connect，2016，5(5)：G1-3.

Please choose a citation manager

Content to export